In recent decades, the emphasis of biomarker research has centered around blood-based markers.
Combining treatments to boost tumor response in lung cancer
Researchers at the Francis Crick Institute, in collaboration with Revolution Medicines, have tested a combination of treatments in mice with lung cancer and shown that